AlzeCure delivers positive NeuroRestore candidate results
The therapy reaches and activates areas of the brain that are central to cognitive enhancement
Read More
Author: Jen Brogan
First patient dosed in AskBio’s AB-1003 trial
Research is evaluating the company’s novel investigational FKRP gene replacement therapy
Read More
NICE rejection for CSL Behring gene therapy
Therapy is a treatment option for adults with severe and moderately severe haemophilia B
Read More
CHMP gives positive opinion recommending authorisation to GSK’s CKD drug
Chronic kidney disease affects roughly 700 million patients worldwide
Read More
AstraZeneca’s Soliris given EU CHMP recommendation for marketing authorisation
The authorisation would include certain patients with refractory generalised myasthenia gravis
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
